1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global mRNA Sequencing Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global mRNA Sequencing Market Perspective (2018-2029)
2.2 mRNA Sequencing Growth Trends by Region
2.2.1 mRNA Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Sequencing Historic Market Size by Region (2018-2023)
2.2.3 mRNA Sequencing Forecasted Market Size by Region (2024-2029)
2.3 mRNA Sequencing Market Dynamics
2.3.1 mRNA Sequencing Industry Trends
2.3.2 mRNA Sequencing Market Drivers
2.3.3 mRNA Sequencing Market Challenges
2.3.4 mRNA Sequencing Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top mRNA Sequencing Players by Revenue
3.1.1 Global Top mRNA Sequencing Players by Revenue (2018-2023)
3.1.2 Global mRNA Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Sequencing Revenue
3.4 Global mRNA Sequencing Market Concentration Ratio
3.4.1 Global mRNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Sequencing Revenue in 2022
3.5 mRNA Sequencing Key Players Head office and Area Served
3.6 Key Players mRNA Sequencing Product Solution and Service
3.7 Date of Enter into mRNA Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans 4 mRNA Sequencing Breakdown Data by Type
4.1 Global mRNA Sequencing Historic Market Size by Type (2018-2023)
4.2 Global mRNA Sequencing Forecasted Market Size by Type (2024-2029) 5 mRNA Sequencing Breakdown Data by Application
5.1 Global mRNA Sequencing Historic Market Size by Application (2018-2023)
5.2 Global mRNA Sequencing Forecasted Market Size by Application (2024-2029) 6 North America
6.1 North America mRNA Sequencing Market Size (2018-2029)
6.2 North America mRNA Sequencing Market Size by Country (2018-2023)
6.3 North America mRNA Sequencing Market Size by Country (2024-2029)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe mRNA Sequencing Market Size (2018-2029)
7.2 Europe mRNA Sequencing Market Size by Country (2018-2023)
7.3 Europe mRNA Sequencing Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific mRNA Sequencing Market Size (2018-2029)
8.2 Asia-Pacific mRNA Sequencing Market Size by Country (2018-2023)
8.3 Asia-Pacific mRNA Sequencing Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America mRNA Sequencing Market Size (2018-2029)
9.2 Latin America mRNA Sequencing Market Size by Country (2018-2023)
9.3 Latin America mRNA Sequencing Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa mRNA Sequencing Market Size (2018-2029)
10.2 Middle East & Africa mRNA Sequencing Market Size by Country (2018-2023)
10.3 Middle East & Africa mRNA Sequencing Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific mRNA Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in mRNA Sequencing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina mRNA Sequencing Introduction
11.2.4 Illumina Revenue in mRNA Sequencing Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) mRNA Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in mRNA Sequencing Business (2018-2023)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies mRNA Sequencing Introduction
11.4.4 Agilent Technologies Revenue in mRNA Sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche mRNA Sequencing Introduction
11.5.4 Roche Revenue in mRNA Sequencing Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare mRNA Sequencing Introduction
11.6.4 GE Healthcare Revenue in mRNA Sequencing Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories mRNA Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in mRNA Sequencing Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm mRNA Sequencing Introduction
11.8.4 Fluidigm Revenue in mRNA Sequencing Business (2018-2023)
11.8.5 Fluidigm Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
